Nanoviricides News

Nanoviricides | 8-K: Current report

Apr 6 05:30

Nanoviricides | 8-K: Current report

Feb 17 05:57

Nanoviricides | 8-K: Current report

Jan 19 13:00

Nanoviricides | DEF 14A: Definitive information statements

Dec 5, 2023 05:08

Nanoviricides | 8-K: Current report

Nov 7, 2023 07:16

Nanoviricides | NT 10-K: Others

Sep 29, 2023 04:44

Nanoviricides | 8-K: Current report

Sep 2, 2023 04:46

Nanoviricides | 8-K: Current report

May 26, 2023 04:31

Nanoviricides | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

May 9, 2023 05:19

Nanoviricides | S-3: Registration statement for specified transactions by certain issuers

May 6, 2023 05:30

Nanoviricides | 8-K: Current report

Apr 1, 2023 05:17

Nanoviricides | 8-K: Current report

Feb 14, 2023 06:01

Nanoviricides | DEFA14A: Others

Dec 23, 2022 07:47

Nanoviricides | 8-K: Current report

Dec 23, 2022 06:11

Nanoviricides | DEF 14A: Definitive proxy statements

Nov 16, 2022 05:30

Nanoviricides | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Nov 5, 2022 04:31

Nanoviricides | 8-K: Current report

Oct 12, 2022 04:32

Nanoviricides | NT 10-K: Others

Sep 30, 2022 00:18

Nanoviricides | 8-K: Current report

Nov 27, 2021 05:30

Nanoviricides | DEF 14A: Definitive proxy statements

Oct 12, 2021 18:15